Blog: MS news

Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says

15 February 2019

Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found.

Masterswitch discovered in body's immune system

12 February 2019

Source Science Daily: Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.

Why not try our Monday evening MS Yoga Class?

8 February 2019

Why not try our Monday evening MS Yoga Class?

Yoga is an ancient discipline bringing together physical, mental and spiritual practices. It is designed to relax your mind and strengthen your body.

Letter calls for ocrelizumab to be made available for people with PPMS

6 February 2019

Source MS Trust: A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS.

Back in September, NICE announced that it would not be recommending ocrelizumab as an NHS treatment for early primary progressive MS. This decision was met with anger and dismay from people with MS and MS charities, and the MS Society started a petition, calling for...

Brain Cells Key to Myelin Grown in Lab and Show Long-Term Survival Essential to Research, Study Reports

6 February 2019

Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with neurons and the astrocytes that are essential to nerve cell health.

These long-surviving spheroids (which the researchers call “human oligodendrocyte spheroids”) will help scientists in...

A Virtual Mindfulness Course for people living with MS

22 January 2019

Mindfulness has been shown to help people cope better with chronic health conditions, including MS, and improve their quality of life.

UK Experts Propose New Guidelines to Treat Women with MS Before, During, After Pregnancy

21 January 2019

Source Multiple Sclerosis News Today: Multiple sclerosis (MS) experts in the United Kingdom have proposed consensus guidelines for the management and treatment of pregnant women with the disease, and couples affected by MS who are planning a pregnancy.

NICE pauses final decision on ocrelizumab for primary progressive MS

2 November 2018

Source MS Trust: NICE has announced that it is pausing the publication of final guidance for ocrelizumab for primary progressive multiple sclerosis.

Medical Cannabis To Be Available On Prescription ‘Within Weeks’

10 October 2018

Source Huffington Post: Medical cannabis will be available on prescription in the UK within a month, according to The Telegraph.

Pages

Category

Archive